Cargando…

Sleep Disturbance as a Potential Modifiable Risk Factor for Alzheimer’s Disease

Sleep disturbance is a common symptom in patients with various neurodegenerative diseases, including Alzheimer’s disease (AD), and it can manifest in the early stages of the disease. Impaired sleep in patients with AD has been attributed to AD pathology that affects brain regions regulating the slee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minakawa, Eiko N., Wada, Keiji, Nagai, Yoshitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412395/ https://www.ncbi.nlm.nih.gov/pubmed/30781802 http://dx.doi.org/10.3390/ijms20040803

Ejemplares similares

Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease
por: Minakawa, Eiko N.
Publicado: (2022)

Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
por: Minakawa, Eiko N., et al.
Publicado: (2021)

Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease
por: Bohnen, Nicolaas I., et al.
Publicado: (2019)

Role of Sleep Disturbance in the Trajectory of Alzheimer’s Disease
por: Kang, Dong Woo, et al.
Publicado: (2017)

Metabolic Disturbances Induced by Sleep Restriction as Potential Triggers for Alzheimer’s Disease
por: García-Aviles, Jesús Enrique, et al.
Publicado: (2021)

Neural Correlates of Sleep Disturbance in Alzheimer’s Disease: Role of the Precuneus in Sleep Disturbance
por: Matsuoka, Teruyuki, et al.
Publicado: (2018)

Clinical management of sleep disturbances in Alzheimer’s disease: current and emerging strategies
por: Urrestarazu, Elena, et al.
Publicado: (2016)

Sleep Disturbances as a Risk Factor for Stroke
por: Koo, Dae Lim, et al.
Publicado: (2018)

Editorial: Additive or synergistic impacts of sleep, circadian rhythm disturbances and other modifiable risk factors on established and novel plasma biomarkers of Alzheimer's disease pathology
por: Bubu, Omonigho M., et al.
Publicado: (2023)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
por: Mizuno, Hideya, et al.
Publicado: (2010)

Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer’s Disease
por: Yin, You, et al.
Publicado: (2016)

Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis
por: Song, Juhyun
Publicado: (2019)

Management of Sleep Disturbances in Parkinson’s Disease
por: Schütz, Lukas, et al.
Publicado: (2022)

Associations between Brain Perfusion and Sleep Disturbance in Patients with Alzheimer's Disease
por: Im, Jooyeon J., et al.
Publicado: (2017)

Progressive sleep disturbance in various transgenic mouse models of Alzheimer’s disease
por: Drew, Victor J., et al.
Publicado: (2023)

Sleep disturbance in mental health problems and neurodegenerative disease
por: Anderson, Kirstie N, et al.
Publicado: (2013)

Disturbed Copper Bioavailability in Alzheimer's Disease
por: Kaden, Daniela, et al.
Publicado: (2011)

Sleep Disturbances in Newborns
por: Yasova Barbeau, Daphna, et al.
Publicado: (2017)

Sleep Disturbances Associated with Parkinson's Disease
por: Suzuki, Keisuke, et al.
Publicado: (2011)

Parkinson's Disease and Sleep/Wake Disturbances
por: Swick, Todd J.
Publicado: (2012)

Sleep patterns and potential risk factors for disturbed sleep quality in patients after surgery for infective endocarditis
por: Hu, Xiang-Ming, et al.
Publicado: (2022)

Modifiable Risk Factors for Alzheimer’s Disease
por: Edwards III, George A., et al.
Publicado: (2019)

Sleep disturbances and suicide risk: A review of the literature
por: Bernert, Rebecca A, et al.
Publicado: (2007)

Possible Neuropathology of Sleep Disturbance Linking to Alzheimer’s Disease: Astrocytic and Microglial Roles
por: Xiao, Shu-Yun, et al.
Publicado: (2022)

Research advances in the study of sleep disorders, circadian rhythm disturbances and Alzheimer’s disease
por: Xiong, Xiangyang, et al.
Publicado: (2022)

E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease
por: Sakai, Ryusuke, et al.
Publicado: (2019)

Insomnia and Other Disturbances of Sleep
Publicado: (1935)

Neurological and Sleep Disturbances in Bronchiectasis
por: Phua, Chun Seng, et al.
Publicado: (2017)

Sleep disturbances in Parkinson’s disease patients and management options
por: Claassen, Daniel O, et al.
Publicado: (2011)

Alzheimer’s disease: risk factors and potentially protective measures
por: Silva, Marcos Vinícius Ferreira, et al.
Publicado: (2019)

Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease
por: Liu, Jia-jia, et al.
Publicado: (2023)

Association between sleep disturbance in Alzheimer’s disease patients and burden on and health status of their caregivers
por: Okuda, Shoki, et al.
Publicado: (2019)

APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia
por: Blackman, Jonathan, et al.
Publicado: (2022)

Altered local and remote functional connectivity in mild Alzheimer’s disease patients with sleep disturbances
por: Wang, Lei, et al.
Publicado: (2023)

Sleep disorders in Alzheimer’s disease: the predictive roles and potential mechanisms
por: Kuang, Huang, et al.
Publicado: (2021)

Managing Sleep Disturbances in Cirrhosis
por: Zhao, Xun, et al.
Publicado: (2016)

Sleep disturbances in autoimmune encephalitis
por: Koo, Dae Lim
Publicado: (2023)

Pediatric sleep disturbances and treatment with melatonin
por: Esposito, Susanna, et al.
Publicado: (2019)

Sleep disturbance in older ICU patients
por: Sterniczuk, Roxanne, et al.
Publicado: (2014)

Sleep Disturbances in Patients with Nonepileptic Seizures
por: Vanek, Jakub, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ni0slpedgphpb92lu19guvpf4